NCT05232266View on ClinicalTrials.gov

The Effectiveness of a Caralluma Fimbriata Extract on Stress, Sleep and Neurotransmitters

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

129

Participants

Timeline

Start Date

February 10, 2022

Primary Completion Date

May 19, 2023

Study Completion Date

May 19, 2023

Conditions
StressSleep
Interventions
DRUG

Caralluma Fimbriata

Caralluma fimbriata in capsule form - taken as a 500mg dose (two 250mg capsules) twice daily, morning and evening with food.

DRUG

Placebo comparator - Microcrystalline cellulose

Placebo comparator in capsule form - taken as a 500mg dose (two 250mg capsules) twice daily, morning and evening with food.

Trial Locations (1)

4006

RDC Clinical Pty Ltd, Newstead

All Listed Sponsors
lead

RDC Clinical Pty Ltd

INDUSTRY